Company intelligence / Profile preview

Canada-Kazakhstan EpiTerapia

Almaty, Kazakhstan

Ownership: Private
Development stage: Other

Overview

Canada-Kazakhstan EpiTerapia Inc. is a biotechnology company specializing in epigenetic diagnostics and non-invasive cancer detection. Founded by renowned geneticist Moshe Szyf, the company leverages DNA methylation signatures from peripheral blood mononuclear cells (PBMC) and circulating tumor DNA (ctDNA) to identify biomarkers for various cancers, including breast, prostate, and cervical cancer. The company operates in close collaboration with Montreal EpiTerapia Inc. and HKG Epitherapeutics to provide advanced diagnostic tools and cell line authentication services. Its research focuses on the host immune system's molecular response to cancer, aiming to provide early detection and personalized healthcare solutions through liquid biopsy technology.

Therapeutic areas: Oncology
Modalities: DNA methylation analysisEpigeneticsLiquid biopsy
Industry: Molecular Diagnostics

Partnerships

HKG EpitherapeuticsKazakh Research Institute of Oncology & RadiologyMcGill University

Beyond the preview

Go deeper on Canada-Kazakhstan EpiTerapia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canada-Kazakhstan EpiTerapia.

Explore the full profile